July 20, 2011 -- Two China biopharmas have completed IPOs on Shenzhen’s ChiNext Exchange. Guangdong Biolight Meditech, a medical device maker whose products include patient monitors and central monitoring systems, raised 262.5 million RMB ($40.6 million). Zhejiang D.A. Diagnostics, a third-party diagnostic services and diagnostic products distributor, raised 301 million RMB ($46.6 million). Both offerings, though modest in size, turned out to be very positive for the IPO investors. More details....
Stock Symbols: (SHE: 300246) (SHE: 300245)
